NRAS and hepatocellular carcinoma: Consistent with the results in the ICGC cohort, MAP2K2, NRAS, and EGF were found to be significantly up-expressed, whereas MCCs were significantly down-expressed in HCC (all P < 0.0001, Figures 4A–D).